Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014

the European Clostridium difficile Infection Surveillance Network (ECDIS-Net)

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Suboptimal laboratory diagnostics for Clostridium difficile infection (CDI) impedes its surveillance and control across Europe. We evaluated changes in local laboratory CDI diagnostics and changes in national diagnostic and typing capacity for CDI during the European C. difficile Infection Surveillance Network (ECDIS-Net) project, through cross-sectional surveys in 33 European countries in 2011 and 2014. In 2011, 126 (61%) of a convenience sample of 206 laboratories in 31 countries completed a survey on local diagnostics. In 2014, 84 (67%) of these 126 laboratories in 26 countries completed a follow-up survey. Among laboratories that participated in both surveys, use of CDI diagnostics deemed ‘optimal’ or ‘acceptable’ increased from 19% to 46% and from 10% to 15%, respectively (p < 0. 001). The survey of national capacity was completed by national coordinators of 31 and 32 countries in 2011 and 2014, respectively. Capacity for any C. difficile typing method increased from 22/31 countries in 2011 to 26/32 countries in 2014; for PCR ribotyping from 20/31 countries to 23/32 countries, and specifically for capillary PCR ribotyping from 7/31 countries to 16/32 countries. While our study indicates improved diagnostic capability and national capacity for capillary PCR ribotyping across European laboratories between 2011 and 2014, increased use of ‘optimal’ diagnostics should be promoted.

Original languageEnglish
JournalEurosurveillance
Volume21
Issue number29
DOIs
Publication statusPublished - Jul 21 2016

Fingerprint

Clostridium Infections
Clostridium difficile
Ribotyping
Polymerase Chain Reaction
Surveys and Questionnaires
Cross-Sectional Studies

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Virology

Cite this

Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. / the European Clostridium difficile Infection Surveillance Network (ECDIS-Net).

In: Eurosurveillance, Vol. 21, No. 29, 21.07.2016.

Research output: Contribution to journalArticle

the European Clostridium difficile Infection Surveillance Network (ECDIS-Net). / Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. In: Eurosurveillance. 2016 ; Vol. 21, No. 29.
@article{92abeeae750147a8bbb57fd2133efdc6,
title = "Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014",
abstract = "Suboptimal laboratory diagnostics for Clostridium difficile infection (CDI) impedes its surveillance and control across Europe. We evaluated changes in local laboratory CDI diagnostics and changes in national diagnostic and typing capacity for CDI during the European C. difficile Infection Surveillance Network (ECDIS-Net) project, through cross-sectional surveys in 33 European countries in 2011 and 2014. In 2011, 126 (61{\%}) of a convenience sample of 206 laboratories in 31 countries completed a survey on local diagnostics. In 2014, 84 (67{\%}) of these 126 laboratories in 26 countries completed a follow-up survey. Among laboratories that participated in both surveys, use of CDI diagnostics deemed ‘optimal’ or ‘acceptable’ increased from 19{\%} to 46{\%} and from 10{\%} to 15{\%}, respectively (p < 0. 001). The survey of national capacity was completed by national coordinators of 31 and 32 countries in 2011 and 2014, respectively. Capacity for any C. difficile typing method increased from 22/31 countries in 2011 to 26/32 countries in 2014; for PCR ribotyping from 20/31 countries to 23/32 countries, and specifically for capillary PCR ribotyping from 7/31 countries to 16/32 countries. While our study indicates improved diagnostic capability and national capacity for capillary PCR ribotyping across European laboratories between 2011 and 2014, increased use of ‘optimal’ diagnostics should be promoted.",
author = "{the European Clostridium difficile Infection Surveillance Network (ECDIS-Net)} and {Van Dorp}, {S. M.} and Notermans, {D. W.} and J. Alblas and P. Gastmeier and S. Mentula and E. Nagy and P. Spigaglia and K. Ivanova and F. Fitzpatrick and F. Barbut and T. Morris and Wilcox, {M. H.} and P. Kinross and C. Suetens and Kuijper, {E. J.}",
year = "2016",
month = "7",
day = "21",
doi = "10.2807/1560-7917.ES.2016.21.29.30292",
language = "English",
volume = "21",
journal = "Eurosurveillance",
issn = "1560-7917",
publisher = "Centre Europeen pour la Surveillance Epidemiologique du SIDA",
number = "29",

}

TY - JOUR

T1 - Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014

AU - the European Clostridium difficile Infection Surveillance Network (ECDIS-Net)

AU - Van Dorp, S. M.

AU - Notermans, D. W.

AU - Alblas, J.

AU - Gastmeier, P.

AU - Mentula, S.

AU - Nagy, E.

AU - Spigaglia, P.

AU - Ivanova, K.

AU - Fitzpatrick, F.

AU - Barbut, F.

AU - Morris, T.

AU - Wilcox, M. H.

AU - Kinross, P.

AU - Suetens, C.

AU - Kuijper, E. J.

PY - 2016/7/21

Y1 - 2016/7/21

N2 - Suboptimal laboratory diagnostics for Clostridium difficile infection (CDI) impedes its surveillance and control across Europe. We evaluated changes in local laboratory CDI diagnostics and changes in national diagnostic and typing capacity for CDI during the European C. difficile Infection Surveillance Network (ECDIS-Net) project, through cross-sectional surveys in 33 European countries in 2011 and 2014. In 2011, 126 (61%) of a convenience sample of 206 laboratories in 31 countries completed a survey on local diagnostics. In 2014, 84 (67%) of these 126 laboratories in 26 countries completed a follow-up survey. Among laboratories that participated in both surveys, use of CDI diagnostics deemed ‘optimal’ or ‘acceptable’ increased from 19% to 46% and from 10% to 15%, respectively (p < 0. 001). The survey of national capacity was completed by national coordinators of 31 and 32 countries in 2011 and 2014, respectively. Capacity for any C. difficile typing method increased from 22/31 countries in 2011 to 26/32 countries in 2014; for PCR ribotyping from 20/31 countries to 23/32 countries, and specifically for capillary PCR ribotyping from 7/31 countries to 16/32 countries. While our study indicates improved diagnostic capability and national capacity for capillary PCR ribotyping across European laboratories between 2011 and 2014, increased use of ‘optimal’ diagnostics should be promoted.

AB - Suboptimal laboratory diagnostics for Clostridium difficile infection (CDI) impedes its surveillance and control across Europe. We evaluated changes in local laboratory CDI diagnostics and changes in national diagnostic and typing capacity for CDI during the European C. difficile Infection Surveillance Network (ECDIS-Net) project, through cross-sectional surveys in 33 European countries in 2011 and 2014. In 2011, 126 (61%) of a convenience sample of 206 laboratories in 31 countries completed a survey on local diagnostics. In 2014, 84 (67%) of these 126 laboratories in 26 countries completed a follow-up survey. Among laboratories that participated in both surveys, use of CDI diagnostics deemed ‘optimal’ or ‘acceptable’ increased from 19% to 46% and from 10% to 15%, respectively (p < 0. 001). The survey of national capacity was completed by national coordinators of 31 and 32 countries in 2011 and 2014, respectively. Capacity for any C. difficile typing method increased from 22/31 countries in 2011 to 26/32 countries in 2014; for PCR ribotyping from 20/31 countries to 23/32 countries, and specifically for capillary PCR ribotyping from 7/31 countries to 16/32 countries. While our study indicates improved diagnostic capability and national capacity for capillary PCR ribotyping across European laboratories between 2011 and 2014, increased use of ‘optimal’ diagnostics should be promoted.

UR - http://www.scopus.com/inward/record.url?scp=85015132564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015132564&partnerID=8YFLogxK

U2 - 10.2807/1560-7917.ES.2016.21.29.30292

DO - 10.2807/1560-7917.ES.2016.21.29.30292

M3 - Article

C2 - 27469624

AN - SCOPUS:85015132564

VL - 21

JO - Eurosurveillance

JF - Eurosurveillance

SN - 1560-7917

IS - 29

ER -